Dear xing

【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint contract

Time:2022-7-31 Edit:2939789029@qq.com

Introduce of【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint contract, Shanghai Songjiang Group DN125 PN10 molded rubber expansion joint contract have received product approvals from various classification and certifying bodies and have undergone a multitude of national and international component and performance tests.

1. Zhejiang Huahai Pharmaceutical Co., Ltd.

【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint contract

Zhejiang Huahai Pharmaceutical Co., Ltd. was founded in 1989. Its predecessor was Linhai Xunqiao Synthetic Chemical Factory. In January 2001, it was changed to Zhejiang Huahai Pharmaceutical Co., Ltd. as a whole. In March 2003, the company’s stock was successfully listed on the Shanghai Stock Exchange. Zhejiang Huahai Pharmaceutical Co., Ltd. is a national high-tech enterprise, a national innovative enterprise and a “five batch” key enterprise recognized by the provincial government. It has a national enterprise technology center and a post-doctoral research station. A pharmaceutical company with the title of “National Environment-Friendly Enterprise”. From 2000 to 2008, it was listed among the “Top Ten Enterprises in the Pharmaceutical Industry in Zhejiang Province” for nine consecutive years.
The company has a registered capital of 299 million yuan, total assets of 1.7 billion yuan, covers an area of ??more than 800,000 square meters, and has more than 2,800 employees. It has set up 11 branches (subsidiaries) in Linhai, Hangzhou, Shanghai and the United States.
The company is mainly engaged in pharmaceutical preparations, raw materials and intermediates, and has formed a product pattern with obvious characteristics that is dominated by cardiovascular drugs, antidepressants and antiviral drugs, and is refined, refined and strong, and serialized and large-scale development. Among them, cardiovascular drug ACE inhibitor products have the largest variety in the world, the largest production and sales volume, and the leading technology level, and enjoy the reputation of “Pulley Expert”. The company’s various management systems are sound, and all products have passed the national GMP certification. It is one of the domestic enterprises that have passed the most international drug quality certification.
In June 2007, the company’s anti-AIDS drug nevirapine passed the US FDA certification with zero defects, becoming the first pharmaceutical company in China to obtain this certification. , has established a proud monument in the development history of China’s pharmaceutical industry.

2.Introduction to the contract of 【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint

【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint contract
3. Introduction of 【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint

【Zhejiang Huahai Pharmaceutical Co., Ltd.】Use fine in damping effect DN125 PN10 molded rubber expansion joint contract

DN125 PN10 molded rubber expansion joint contract have received product approvals from various classification and certifying bodies and have undergone a multitude of national and international component and performance tests.

Related Link: Non Metal Expansion Joint and metallic compensator product center Fully automated production From China


+86 13032112360 Send SMS